Santhera Pharmaceuticals
Clinical trials sponsored by Santhera Pharmaceuticals, explained in plain language.
-
New hope for boys with Muscle-Wasting disease: safer steroid shows promise
Disease control CompletedThis study tested vamorolone, a new type of steroid medication, in boys with Duchenne muscular dystrophy (DMD). It aimed to see if the drug was safe and how the body processed it, while also looking for early signs of benefit. The trial included 54 boys, aged 2-4 and 7-18, who to…
Phase: PHASE2 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test how two drugs interact in healthy volunteers
Knowledge-focused CompletedThis study aimed to understand if and how the drug vamorolone changes the way the body processes another drug called midazolam. It involved 18 healthy adults who took both drugs over a two-week period while researchers took frequent blood samples. The main goal was to measure dru…
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 02, 2026 03:41 UTC
-
Early drug test probes Body's salt control system
Knowledge-focused CompletedThis early-stage study aimed to understand if an experimental drug called vamorolone can block a specific receptor in the body that helps regulate salt and water balance. It involved 30 healthy volunteers who received either vamorolone, a comparison drug, or no treatment, alongsi…
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC